NYSE - Delayed Quote USD

Teleflex Incorporated (TFX)

217.64 -0.93 (-0.43%)
At close: May 17 at 4:00 PM EDT
217.64 0.00 (0.00%)
After hours: May 17 at 5:30 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,001,406.00
2,974,489.00
2,791,041.00
2,809,563.00
2,537,156.00
Cost of Revenue
1,329,721.00
1,327,558.00
1,259,954.00
1,259,961.00
1,212,282.00
Gross Profit
1,671,685.00
1,646,931.00
1,531,087.00
1,549,602.00
1,324,874.00
Operating Expense
1,228,301.00
1,084,218.00
1,017,567.00
990,926.00
863,315.00
Operating Income
443,384.00
562,713.00
513,520.00
558,676.00
461,559.00
Net Non Operating Interest Income Expense
-75,824.00
-72,301.00
-53,352.00
-55,641.00
-65,336.00
Other Income Expense
-56,838.00
-56,400.00
-14,249.00
56,433.00
-38,491.00
Pretax Income
310,722.00
434,012.00
445,919.00
559,468.00
357,732.00
Tax Provision
14,705.00
76,440.00
83,003.00
74,349.00
21,931.00
Net Income Common Stockholders
294,869.00
356,328.00
363,139.00
485,374.00
335,324.00
Diluted NI Available to Com Stockholders
294,869.00
356,328.00
363,139.00
485,374.00
335,324.00
Basic EPS
6.27
7.58
7.74
10.38
7.21
Diluted EPS
6.23
7.53
7.68
10.23
7.09
Basic Average Shares
47,010.75
46,981.00
46,898.00
46,774.00
46,488.00
Diluted Average Shares
47,331.25
47,304.00
47,309.00
47,427.00
47,287.00
Total Operating Income as Reported
386,546.00
506,313.00
499,725.00
628,095.00
423,068.00
Total Expenses
2,558,022.00
2,411,776.00
2,277,521.00
2,250,887.00
2,075,597.00
Net Income from Continuing & Discontinued Operation
294,869.00
356,328.00
363,139.00
485,374.00
335,324.00
Normalized Income
350,165.13
404,045.60
374,514.69
436,191.59
371,944.05
Interest Income
13,604.00
12,781.00
912.00
1,328.00
1,158.00
Interest Expense
89,428.00
85,082.00
54,264.00
56,969.00
66,494.00
Net Interest Income
-75,824.00
-72,301.00
-53,352.00
-55,641.00
-65,336.00
EBIT
400,150.00
519,094.00
500,183.00
616,437.00
424,226.00
EBITDA
648,485.00
761,212.00
730,773.00
853,799.00
651,478.00
Reconciled Cost of Revenue
1,329,721.00
1,327,558.00
1,259,954.00
1,259,961.00
1,212,282.00
Reconciled Depreciation
248,335.00
242,118.00
230,590.00
237,362.00
227,252.00
Net Income from Continuing Operation Net Minority Interest
296,017.00
357,572.00
362,916.00
485,119.00
335,801.00
Total Unusual Items Excluding Goodwill
-56,838.00
-56,400.00
-14,249.00
56,433.00
-38,491.00
Total Unusual Items
-56,838.00
-56,400.00
-14,249.00
56,433.00
-38,491.00
Normalized EBITDA
705,323.00
817,612.00
745,022.00
797,366.00
689,969.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-2,689.87
-9,926.40
-2,650.31
7,505.59
-2,347.95
12/31/2020 - 3/17/1980

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

COO The Cooper Companies, Inc.
97.31
-0.60%
 
WST West Pharmaceutical Services, Inc.
355.64
+0.43%
 
ICUI ICU Medical, Inc.
103.99
-2.15%
 
XRAY DENTSPLY SIRONA Inc.
28.28
-0.35%
 
MMSI Merit Medical Systems, Inc.
81.89
-0.45%
 
HAE Haemonetics Corporation
95.73
+0.98%
 
RMD ResMed Inc.
218.57
-0.64%
 
OSUR OraSure Technologies, Inc.
4.9200
-5.93%
 
RGEN Repligen Corporation
171.94
+0.53%
 
BAX Baxter International Inc.
35.25
+0.23%